Results 41 to 50 of about 106,855 (202)

Platelet Levels Associated With Bleeding Risk for Dental Interventions: A Systematic Review

Oral Diseases, Volume 32, Issue 6, Page 1506-1517, June 2026.
ABSTRACT Objectives To evaluate evidence in relation to postoperative bleeding in humans aged ≥ 16 with preoperative platelet counts < 50,000/μL, compared to those above, undergoing dental interventions. Methods Quantitative synthesis without meta‐analysis was conducted through an electronic search conducted on Ovid MEDLINE and Embase from 1946 to ...
Guang Xu David Lim, Fatima Al Sarraf, Hana Cho, Navdeep Kumar   +3 more
wiley   +1 more source

An extracellular residue determines the agonist specificity of V2 vasopressin receptors [PDF]

, 1995
The specific V2 agonist 1-deamino [8-d-arginine]-vasopressin (dDAVP), used for treatment of central diabetes insipidus, binds to vasopressin V2 receptors from human, bovine and rat kidney with an affinity that is similar to that of the natural hormone ...
Gorbulev, V., Gorbulev, Valentin, Valentin Gorbulev, Fahrenholz, Falk, Falk Fahrenholz, Ufer, E., Postina, R., Fahrenholz, F., Postina, Rolf, Elke Ufer, Ufer, Elke, Rolf Postina   +11 more
core   +1 more source

Understanding Treatment Care and Delays in Acquired Hemophilia A: A Population‐Based Study From Nova Scotia, Canada

eJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Objectives Acquired Hemophilia A (AHA) is a rare, potentially life‐threatening bleeding disorder caused by autoantibodies against factor VIII (FVIII). We aimed to characterize patients with AHA in Nova Scotia, Canada, and assess diagnostic delays.
Rachelle Blackman, Luke Y. C. Chen, Mary‐Margaret Keating, Jason Quinn, Sue Robinson   +4 more
wiley   +1 more source

[7-Glycine]deamino-1-carba-vasopressin: Synthesis and pharmacological properties

, 1981
[8-Arginine]deamino-1-carba-vasopressin and its 7-glycine derivative were prepared by condensation of the amino-terminal, cyclic part of the molecule with carboxy-terminal tripeptide amides.
Tomislav Barth, Karel Jošt, František Brtník   +2 more
core   +1 more source

Effectiveness of Octocog Alfa (BAY 81‐8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under‐Represented Subgroups

European Journal of Haematology, Volume 115, Issue 5, Page 484-492, November 2025.
ABSTRACT Objectives To evaluate the real‐world effectiveness of octocog alfa (BAY 81‐8973; Kovaltry) in people with haemophilia A (PwHA), including under‐represented subgroups. Methods We retrospectively analysed the American Thrombosis and Hemostasis Network (ATHN) dataset to identify the characteristics, treatment/clinical histories and annualised ...
Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht   +4 more
wiley   +1 more source

Copeptin levels remain unchanged during the menstrual cycle [PDF]

, 2014
Copeptin, a surrogate marker for arginin vasopressin production, is evaluated as an osmo-dependent stress and inflammatory biomarker in different diseases.
Christian Schindler (71594), Mueller, B., Mirza, Uzma, Beat Mueller (300968), Jardena J. Puder (520033), Mirjam Christ-Crain (15611), Puder, Jardena J., Claudine A. Blum (409092), Beat Mueller, Christ-Crain, Mirjam, Mirjam Christ-Crain, Christian Schindler, Uzma Mirza, Jardena J Puder, Puder, J.J., Claudine A Blum, Blum, Claudine A., Mueller, Beat, Schindler, Christian, Blum, C.A., Schindler, C., Mirza, U., Uzma Mirza (568903), Christ-Crain, M.   +23 more
core   +1 more source

Desmopressin (DDAVP): indications and practicalities

Swiss Medical Weekly
BACKGROUND: Desmopressin (1-deamino-8-D-arginine vasopressin, or DDAVP) is available in Switzerland for the treatment of non-severe haemophilia A and von Willebrand disease.
Eugenia Biguzzi, Alessandro Casini, Alessandra Bosch, Johanna A. Kremer Hovinga, Lorenzo Alberio, Pierre Fontana, Anne Angelillo-Scherrer, Bernhard Gerber, Working Party of Haemostasis of the Swiss Society of Haematology, Swiss Haemophilia Network   +9 more
doaj   +1 more source

Management of pregnancy and childbirth in Glanzmann thrombasthenia: A case series and review

British Journal of Haematology, Volume 207, Issue 4, Page 1702-1708, October 2025.
To illustrate the challenges in the management of women with Glanzmann thrombasthenia (GT) planning a pregnancy, we conducted a literature review and present a case series of eight women giving detailed descriptions of reproductive health problems, platelet alloimmunisation, treatment to prevent post‐partum haemorrhage and neonatal outcomes.
Karlijn H. G. Rutten, Olga Tsiamita, Quentin Van Thillo, Priyanka Raheja, Mandeep Kaler, Karin P. M. van Galen, Matthew Hogg, Louise Bowles, Roger E. G. Schutgens, Suthesh Sivapalaratnam   +9 more
wiley   +1 more source

Synthesis of oxytocin, arginine-vasopressin and its deamino-analogue using 2,4,6-trimethylbenzyl group for protection of the cysteine sulfur

, 1981
Preparation of oxytocin, arginine-vasopressin and its deamino-analogue serves as an example of use of 2,4,6-trimethylbenzyl group for protection of the cysteine sulfur atom in the peptide synthesis. This modified benzyl group is sufficiently stable under
Tomislav Barth, Karel Jošt, Milan Krojidlo, František Brtník   +3 more
core   +1 more source

Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively [PDF]

, 1992
The potency of oxytocin (OT) in evoking ACTH secretion by isolated, superfused rat adenohypophyseal corticotrophs and its enhancement by CRF and arginine vasopressin (AVP) were analyzed.
Link, H., Föhr, K. J., Dayanithi, G., Gratzl, Manfred   +3 more
core   +1 more source